Relmada outlines 2026 trial launches for NDV-01 and sepranolone as pipeline advances Relmada outlines 2026 trial launches for NDV-01 and sepranolone as pipeline advances Post ContentrlmdRead More You might also be interested in reading Square’s value could 5X thanks to Afterpay deal: Pomp. August 8, 2025 In Mainstream ← Previous post Next post →